undamentalytics Newsletter

Hutchens James Justin: insider trades

Chief executive, Officer at 2 companies we cover. 7 open-market purchases and 6 sales not made under a pre-set plan, reported from August 8, 2011 to February 11, 2016.

Would copying Hutchens James Justin’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 7 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on August 9, 2011 into $19,686 by November 2, 2026, +4.6% a year. The copy held shares only 21% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $20,781, +4.9% a year (the S&P 500 held throughout made $84,048, +15.0% a year). Beta against the index was 0.10. Twelve months after each report, the average purchase was −0.8% against the S&P 500 (median +0.3%), and 57% beat it. Measured from the trade date, the insider’s own timing, the average was −0.4%. After their sales, the shares moved −5.6% against the index over 12 months on average (a negative figure means selling was the right call); 67% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$25.0k$50.0k$75.0k 20112013201520172019202120232025 $84.0k$20.8k$19.7k
Copying Hutchens James JustinS&P 500, same days investedS&P 500, held throughout $10,000 copying Hutchens James Justin’s open-market purchases from August 9, 2011, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
+4.6%
S&P 500, same days invested
+4.9% (held throughout +15.0%)
Time in shares
21%
Sharpe ratio (S&P 500)
0.31 (0.81)
Biggest drop (S&P 500)
−32% (−34%)
Market sensitivity (beta)
0.10
Purchases copied
7

Trade by trade

Hutchens James Justin: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 7 −1.5% −2.8% 29% 5 0.07 0.95 No reliable evidence
Purchases, 6 months after the report 7 +4.5% +3.6% 71% 5 1.09 0.34 No reliable evidence
Purchases, 12 months after the report 7 −0.8% +0.3% 57% 5 −0.19 0.86 No reliable evidence
Purchases, 12 months after the trade 7 −0.4% −0.1% 43% 5 −0.29 0.78 No reliable evidence
Sales, 3 months after the report 6 +0.7% −2.1% 50% 3 — — Not enough years
Sales, 12 months after the report 6 −5.6% −3.5% 67% 3 — — Not enough years
Sales, 12 months after the trade 6 −3.8% −0.4% 50% 3 — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
National Health Investors Inc NHI CEO and President56August 8, 2011April 2, 2015
Healthpeak Properties DOC EVP & CHIEF INVEST OFC/SH+CARE20November 12, 2015February 11, 2016

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
February 11, 2016February 10, 2016 DOC Purchase $274,700 +22.1%+9.0%+2.2%
November 12, 2015November 11, 2015 DOC Purchase $99,270 −10.9%−4.6%−8.3%
April 2, 2015March 31, 2015 NHI Sale $418,047 −11.0%−3.6%−2.6%
August 7, 2014August 6, 2014 NHI Purchase $125,256 +3.1%−4.7%−1.3%
September 10, 2013September 10, 2013 NHI Purchase $27,385 −1.6%+0.3%−0.1%
June 3, 2013June 3, 2013 NHI Purchase $100,190 −14.6%−16.2%−15.4%
November 30, 2012November 30, 2012 NHI Sale $94,129 +11.7%−20.5%−21.2%
November 21, 2012November 19, 2012 NHI Sale $267,500 +14.2%−17.2%−12.2%
June 15, 2012June 14, 2012 NHI Sale $250,800 −4.2%−3.3%+2.0%
May 31, 2012May 29, 2012 NHI Sale $485,800 0.0%+8.8%+9.4%
August 26, 2011August 26, 2011 NHI Sale $1,829,195 −6.6%+2.2%+1.9%
August 25, 2011August 25, 2011 NHI Purchase $65,235 −5.6%+1.9%+2.1%
August 8, 2011August 8, 2011 NHI Purchase $79,820 −2.8%+8.3%+18.1%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Hutchens James Justin traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.